… Several sentinel phase III randomized trials have recently been published challenging
traditional radiation therapy (RT) practices for small cell lung cancer (SCLC). This American …

… lung cancer remains controversial. The majority of these trials did not have enough …
radiotherapy contributes to a moderate increase in overall survival in limited small-cell lung cancer…

… Radiotherapy (RT) and chemotherapy continue to be widely utilized in small cell lung cancer
… In most limited stage (LS)-SCLC cases, the standard initial therapy remains concurrent …

… About 20% of patients with lung cancer have small-cell lung cancer (SCLC) and, … Small-cell
lung cancer is a rapidly proliferating tumor that is responsive to chemotherapy. Radiotherapy …

… standard practice for extensive stage small-cell lung cancer. The use of a practical minimum
requirement of at least a response within the thorax, even if not meeting the formal criteria …

… trial to compare stereotactic ablative body radiotherapy (SABR) with standard radiotherapy
in patients who had pathologically proven non-small cell lung cancer at stage T1–T2aN0M0, …

… Will an increase in loco-regional tumor control by a more intensive and higher dose of … in
survival following chemo-radiotherapy for stage III non-small cell lung cancer? No randomized …

… Given the perceived intrinsic radiosensitivity, SCLC is historically treated with lower doses
of radiation than non-small-cell lung cancer. However, the local control is about 30–50%, and …

… Early concomitant and accelerated radiotherapy … standard therapy of small cell lung cancer.
Particular emphasis is given to the importance of concomitant and accelerated radiotherapy …

… Lung cancer is the most commonly diagnosed cancer and biggest cause of cancer mortality
worldwide with non-small cell lung cancer … Radiotherapy (RT) plays a key role in its …